Edwards Lifesciences Corp - Common Stock (EW)

Historical Holders from Q1 2014 to Q1 2025

Symbol
EW on NYSE
CUSIP
28176E108
Type / Class
Equity / Common Stock
Shares outstanding
590M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
501M
Holdings value
$37.1B
% of all portfolios
0.024%
Grand Portfolio weight change
+0.004%
Number of holders
1210
Number of buys
448
Number of sells
-624
Average Value change %
0%
Average buys %
+0.004%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edwards Lifesciences Corp - Common Stock (EW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.72% $5.01B 69.1M The Vanguard Group Dec 31, 2024

Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 12.3M $893M -$83.3M $72.48 224
2024 Q4 501M $37.1B +$1.96B $74.03 1,210
2024 Q3 469M $30.9B -$2.21B $65.99 1,169
2024 Q2 491M $45.4B +$1.46B $92.37 1,268
2024 Q1 478M $45.6B +$212M $95.56 1,258
2023 Q4 476M $36.3B -$388M $76.25 1,209
2023 Q3 481M $33.3B -$195M $69.28 1,185
2023 Q2 482M $45.4B -$1.07B $94.33 1,243
2023 Q1 492M $40.7B -$940M $82.73 1,206
2022 Q4 484M $36.2B +$96.3M $74.61 1,188
2022 Q3 494M $40.9B -$10.6M $82.63 1,204
2022 Q2 507M $48.1B +$245M $95.09 1,230
2022 Q1 505M $59.4B -$979M $117.72 1,279
2021 Q4 513M $66.4B -$140M $129.55 1,289
2021 Q3 511M $57.9B +$234M $113.21 1,206
2021 Q2 509M $52.8B +$553M $103.57 1,162
2021 Q1 506M $42.3B -$433M $83.64 1,115
2020 Q4 505M $46B +$38.3M $91.23 1,128
2020 Q3 514M $41B +$886M $79.82 1,059
2020 Q2 499M $34.5B +$22.7B $69.11 1,008
2020 Q1 167M $31.5B -$686M $188.62 975
2019 Q4 171M $40B +$46.2M $233.29 1,061
2019 Q3 172M $37.7B -$177M $219.91 945
2019 Q2 173M $31.9B +$969M $184.74 900
2019 Q1 175M $33.5B -$277M $191.33 908
2018 Q4 177M $27B +$77.3M $153.17 857
2018 Q3 175M $30.5B +$112M $174.10 841
2018 Q2 175M $25.5B +$595M $145.57 826
2018 Q1 174M $24.3B +$71.8M $139.52 800
2017 Q4 171M $19.3B -$327M $112.71 760
2017 Q3 177M $19.3B +$155M $109.31 733
2017 Q2 175M $20.7B -$7.81M $118.24 711
2017 Q1 176M $16.6B +$724M $94.07 676
2016 Q4 178M $16.7B -$384M $93.70 663
2016 Q3 179M $21.6B +$89.3M $120.56 683
2016 Q2 178M $17.7B +$149M $99.73 678
2016 Q1 176M $15.5B -$95.2M $88.21 635
2015 Q4 183M $14.4B +$7.51B $78.98 590
2015 Q3 87.9M $12.5B +$382M $142.17 559
2015 Q2 83.3M $11.9B -$842M $142.43 570
2015 Q1 90.8M $12.9B -$25.3M $142.46 566
2014 Q4 91.8M $11.7B -$78.9M $127.38 552
2014 Q3 91.2M $9.32B -$118M $102.15 480
2014 Q2 93.3M $8.01B -$353M $85.84 423
2014 Q1 97.6M $7.24B -$57.6M $74.17 402